O. Danne

Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes.

A. Wu, M. Möckel, U. Frei, 2001, Clinica chimica acta; international journal of clinical chemistry.

The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes.

A. Wu, M. Möckel, U. Frei, 2000, Clinica chimica acta; international journal of clinical chemistry.

Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events.

M. Möckel, L. Röcker, U. Frei, 1998, European heart journal.

Left ventricular hypertrophy regression during antihypertensive treatment

H. Eichstaedt, O. Danne, R. Schroeder, 2004, The clinical investigator.

Reference values for cardiac troponins I and T in a goal-oriented concept of health: cardiac marker values in a series of outpatients without acute coronary syndromes.

A. Wu, R. Dietz, A. Schmidt, 2004, Clinica chimica acta; international journal of clinical chemistry.

Ischemia-Modified Albumin, Free Fatty Acids, Whole Blood Choline, B-Type Natriuretic Peptide, Glycogen Phosphorylase BB, and Cardiac Troponin

A. Wu, M. Möckel, P. Crosby, 2003 .

Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach

W. Koenig, R. Dietz, M. Möckel, 2007, Clinical Research in Cardiology.